共 16 条
[1]
Alderman M H, 1988, Health Psychol, V7 Suppl, P283, DOI 10.1037/h0090278
[3]
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]
[4]
Braeckman L, 1996, EUR HEART J, V17, P1808
[6]
Chalmers J, 1999, J HYPERTENS, V17, P151
[7]
De Henauw S, 1998, J HYPERTENS, V16, P277
[8]
Fogari R, 1997, J Cardiovasc Risk, V4, P209, DOI 10.1097/00043798-199706000-00008
[9]
JOFFRES MR, 1992, CAN MED ASSOC J, V146, P1997
[10]
DISCONTINUATION OF AND CHANGES IN TREATMENT AFTER START OF NEW COURSES OF ANTIHYPERTENSIVE DRUGS - A STUDY OF A UNITED-KINGDOM POPULATION
[J].
BMJ-BRITISH MEDICAL JOURNAL,
1995, 311 (7000)
:293-295